Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details Narrative)

Stock Based Compensation (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended			9 Months Ended
Stock Based Compensation (Details Narrative) - USD ($)	Jul. 08, 2020	Jun. 15, 2020	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock based compensation			$ 369,427		$ 0	$ 619,176	$ 1,762,736
Stock Issued During Period, Value				$ 200,000
January 1, 2020 [Member]
Common stock, shares granted						1,000,000
Stock Issued During Period, Value						$ 200,000
Intrinsic Value[Member]
Closing stock price			$ 0.35			$ 0.35
Nonqualified Stock Options[Member]
Exercise price		$ 0.19
Common stock, shares granted		250,000
Stock Issued During Period, Value		$ 37,882
Debt conversion description		The options granted are exercisable at $0.19 per share, representing the fair market value of the common stock on the date of grant as determined under the 2017 Plan. Fifty percent of the options are fully vested and exercisable as of the date of grant and fifty percent of the options vest on April 1, 2021.
Board of Directors [Member]
Exercise price	$ 0.19
General and administrative expenses	$ 246,965
Vested and exercisable expire	5 years
Stock options descripton	The Company approved an amendment to the 2017 Plan to increase the maximum number of shares of common stock that may be issued under the 2017 Plan from 8,000,0000 to 12,000,000 shares. On the same date, the Company granted nonqualified stock options to the following executive officers to each acquire 500,000 shares of the Company’s common stock: Richard MacPherson (President and Chief Executive Officer), John Pavlish (Senior Vice President and Chief Technology Officer) and James Trettel (Vice President of Operations); and, also granted nonqualified stock options to the following persons to each acquire 250,000 shares of the Company’s common stock: Christopher Greenberg (Chairman of the Board) and David M. Kaye (director).